Chemoinformaics analysis of POTASSIUM;2-HYDROXY-2-OXOACETATE
| Molecular Weight | 128.124 | nRot | 0 |
| Heavy Atom Molecular Weight | 127.116 | nRig | 9 |
| Exact Molecular Weight | 127.951 | nRing | 0 |
| Solubility: LogS | -3.388 | nHRing | 0 |
| Solubility: LogP | 3.263 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 8 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 1 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 2 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 50.2748 |
| nHD | 1 | BPOL | 3.60721 |
| QED | 0.603 |
| Synth | 4.086 |
| Natural Product Likeliness | 2.33 |
| NR-PPAR-gamma | 0.28 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.064 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.552 |
| MDCK | 0.0000236 |
| BBB | 0.798 |
| PPB | 0.841726 |
| VDSS | 1.149 |
| FU | 0.379005 |
| CYP1A2-inh | 0.103 |
| CYP1A2-sub | 0.15 |
| CYP2c19-inh | 0.055 |
| CYP2c19-sub | 0.904 |
| CYP2c9-inh | 0.108 |
| CYP2c9-sub | 0.754 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.594 |
| CYP3a4-inh | 0.11 |
| CYP3a4-sub | 0.245 |
| CL | 6.063 |
| T12 | 0.243 |
| hERG | 0.013 |
| Ames | 0.009 |
| ROA | 0.017 |
| SkinSen | 0.795 |
| Carcinogencity | 0.128 |
| EI | 0.965 |
| Respiratory | 0.33 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.708037 |